Sabra Healthcare REIT, Inc. 7.125% Preferred Series A
SBRAP
SBRAP was delisted on the 31st of May, 2018.
0 hedge funds and large institutions have $0 invested in Sabra Healthcare REIT, Inc. 7.125% Preferred Series A in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $1.88M → $0 (-$1.88M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Asset Management One
Tokyo,
Japan
|
-$1.39M |
| 2 |
VHAM
Van Hulzen Asset Management
El Dorado Hills,
California
|
-$492K |
SBRAP Hedge Fund Activity: Q4 2016 in Review
0 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT, Inc. 7.125% Preferred Series A (SBRAP) for Q4 2016, worth a combined $0 — down 100% from $1.88M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SBRAP and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Asset Management One, exiting entirely with an estimated $1.39M sold.
- 0 institutional investors held Sabra Healthcare REIT, Inc. 7.125% Preferred Series A (SBRAP) as of Q4 2016, down from 2 in Q3 2016.
- Funds reported $0 of Sabra Healthcare REIT, Inc. 7.125% Preferred Series A stock for Q4 2016, down 100% quarter-over-quarter.
- 0 funds opened new Sabra Healthcare REIT, Inc. 7.125% Preferred Series A positions in Q4 2016 and 2 closed out, a net change of -2 holders.
- The largest Sabra Healthcare REIT, Inc. 7.125% Preferred Series A seller in Q4 2016 was Asset Management One, an estimated $1.39M sold.
Based on aggregated 13F filings for Q4 2016.